• 1. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 2. An automatic method for the determination of anionic surface-active material in water
  Analyst, 1966,91, 113-118
• 3. An auto-correction laser photoacoustic spectrometer based on 2f/1f wavelength modulation spectroscopy
  Ke Chen,Shuai Liu,Liang Mei,Feng Jin,Bo Zhang,Fengxiang Ma,Yewei Chen,Hong Deng,Min Guo,Qingxu Yu Analyst, 2020,145, 1524-1530
• 4. An autoreduction method to prepare plasmonic gold-embedded polypeptide micelles for synergistic chemo-photothermal therapy?
  Xingjie Wu,Linzhu Zhou,Yue Su,Chang-Ming Dong J. Mater. Chem. B, 2016,4, 2142-2152
• 5. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498

4-Amino-2-iodo-benzoic Acid Methyl Ester (CAS No. 98546-30-6): A Key Intermediate in Modern Pharmaceutical Synthesis

4-Amino-2-iodo-benzoic Acid Methyl Ester, identified by its CAS number 98546-30-6, is a versatile intermediate that has garnered significant attention in the field of pharmaceutical synthesis. This compound, characterized by its amino and iodo substituents on a benzoic acid backbone with a methyl ester group, plays a crucial role in the development of various therapeutic agents. Its unique structural properties make it a valuable building block for synthesizing complex molecules, particularly in the realm of drug discovery and development.

The significance of 4-amino-2-iodo-benzoic Acid Methyl Ester lies in its ability to undergo a variety of chemical transformations, enabling the construction of diverse pharmacophores. The presence of both an amino group and an iodo substituent provides multiple reaction sites for functionalization, making it an ideal candidate for medicinal chemists seeking to develop novel compounds. These functional groups can be selectively modified through various organic reactions, such as nucleophilic aromatic substitution, cross-coupling reactions, and condensation reactions, thereby facilitating the synthesis of a wide range of derivatives.

In recent years, there has been a surge in research focused on developing new therapeutic agents with improved efficacy and reduced side effects. 4-Amino-2-iodo-benzoic Acid Methyl Ester has emerged as a critical intermediate in this endeavor. Its application in the synthesis of small-molecule inhibitors has been particularly noteworthy. For instance, studies have demonstrated its utility in the preparation of kinase inhibitors, which are essential for treating various cancers and inflammatory diseases. The iodo group on the benzoic acid ring allows for palladium-catalyzed cross-coupling reactions, such as Suzuki-Miyaura and Stille couplings, which are pivotal in constructing biaryl structures found in many bioactive molecules.

The pharmaceutical industry has also leveraged 4-amino-2-iodo-benzoic Acid Methyl Ester in the development of antimicrobial agents. The amino group can be further functionalized to introduce additional pharmacophoric elements that enhance binding affinity to bacterial enzymes or receptors. Additionally, the methyl ester group can be hydrolyzed to yield a carboxylic acid functionality, expanding the scope of possible derivatives. These modifications have led to the discovery of novel compounds with potent antimicrobial activity, addressing the growing challenge of antibiotic resistance.

Advances in synthetic methodologies have further enhanced the utility of 4-amino-2-iodo-benzoic Acid Methyl Ester. The development of more efficient and selective catalytic systems has enabled chemists to perform complex transformations with higher yields and fewer byproducts. For example, transition-metal-catalyzed C-H activation techniques have opened new avenues for constructing intricate molecular architectures from this intermediate. Such innovations have not only streamlined the synthesis process but also allowed for greater flexibility in drug design.

The role of computational chemistry in optimizing synthetic routes has been instrumental in maximizing the potential of 4-amino-2-iodo-benzoic Acid Methyl Ester. By employing molecular modeling and density functional theory (DFT) calculations, researchers can predict reaction outcomes and identify optimal conditions for synthesis. This approach has led to more efficient production methods and has helped overcome synthetic challenges that were previously insurmountable. As computational tools continue to evolve, their integration into drug discovery pipelines will further enhance the impact of this versatile intermediate.

In conclusion, 4-Amino-2-iodo-benzoic Acid Methyl Ester (CAS No. 98546-30-6) represents a cornerstone in modern pharmaceutical synthesis. Its unique structural features and reactivity make it an indispensable tool for medicinal chemists striving to develop innovative therapeutic agents. The ongoing research into its applications in kinase inhibition, antimicrobial drug development, and other areas underscores its importance in advancing healthcare solutions. As synthetic methodologies and computational techniques continue to progress, the potential applications of this compound will undoubtedly expand, solidifying its role as a key intermediate in pharmaceutical innovation.

• 147494-20-0(methyl 2-amino-6-iodobenzoate)
• 61566-60-7(Benzoic acid, 4-amino-2-iodo-, hydrochloride)
• 154921-11-6(Dimethyl 5-amino-2,4,6-triiodoisophthalate)
• 1806924-07-1(Methyl 3-amino-2,4-diiodobenzoate)
• 144551-00-8(Benzoic acid, 3-amino-2-iodo-, ethyl ester)
• 217314-45-9(Methyl 3-amino-5-iodobenzoate)
• 283173-76-2(Methyl 3-amino-2-iodobenzoate)
• 73655-51-3(4-Amino-2-iodo-benzoic Acid)
• 1065102-79-5(Methyl 5-amino-2-iodobenzoate)
• 21324-00-5(Methyl 3-amino-5-iodo-4-methylbenzoate)